Related Experiment Video
Updated: Jul 14, 2026

In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages
Published on: December 30, 2017
Identification of miRNAs that target Fcγ receptor-mediated phagocytosis during macrophage activation syndrome
Kontham Kulangara Varsha1, Xiaoming Yang1, Alkeiver S Cannon1
1Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC, United States.
Abstract:
Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile arthritis, accompanied by cytokine storm and hemophagocytosis. In addition, COVID-19-related hyperinflammation shares clinical features of MAS. Mechanisms that activate macrophages in MAS remain unclear. Here, we identify the role of miRNA in increased phagocytosis and interleukin-12 (IL-12) production by macrophages in a murine model of MAS. MAS significantly increased F4/80+ macrophages and phagocytosis in the mouse liver. Gene expression profile revealed the induction of Fcγ receptor-mediated phagocytosis (FGRP) and IL-12 production in the liver. Phagocytosis pathways such as High-affinity IgE receptor is known as Fc epsilon RI -signaling and pattern recognition receptors involved in the recognition of bacteria and viruses and phagosome formation were also significantly upregulated. In MAS, miR-136-5p and miR-501-3p targeted and caused increased expression of Fcgr3, Fcgr4, and Fcgr1 genes in FGRP pathway and consequent increase in phagocytosis by macrophages, whereas miR-129-1-3p and miR-150-3p targeted and induced Il-12. Transcriptome analysis of patients with MAS revealed the upregulation of FGRP and FCGR gene expression. A target analysis of gene expression data from a patient with MAS discovered that miR-136-5p targets FCGR2A and FCGR3A/3B, the human orthologs of mouse Fcgr3 and Fcgr4, and miR-501-3p targets FCGR1A, the human ortholog of mouse Fcgr1. Together, we demonstrate the novel role of miRNAs during MAS pathogenesis, thereby suggesting miRNA mimic-based therapy to control the hyperactivation of macrophages in patients with MAS as well as use overexpression of FCGR genes as a marker for MAS classification.
Insights
MicroRNAs (miRNAs) drive macrophage hyperactivation in Macrophage Activation Syndrome (MAS) by increasing Fc gamma receptor-mediated phagocytosis and IL-12 production. This suggests miRNA-based therapies for MAS treatment.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Macrophage Activation Syndrome (MAS) is a severe complication of systemic juvenile arthritis and shares features with COVID-19 hyperinflammation.
- The precise mechanisms activating macrophages in MAS are not fully understood.
- Identifying these mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of microRNAs (miRNAs) in macrophage activation during MAS.
- To elucidate the molecular pathways, including phagocytosis and cytokine production, regulated by miRNAs in MAS.
- To explore potential therapeutic targets and diagnostic markers for MAS.
Main Methods:
- Utilized a murine model of MAS to study macrophage activity.
- Performed gene expression profiling to identify upregulated pathways and genes.
- Analyzed miRNA targets using transcriptome data from both murine models and human MAS patients.
Main Results:
- MAS induced increased macrophage populations and phagocytosis in the liver.
- Upregulation of Fc gamma receptor-mediated phagocytosis (FGRP) and Interleukin-12 (IL-12) production was observed.
- Specific miRNAs (miR-136-5p, miR-501-3p) were found to increase Fcgr gene expression and phagocytosis, while others (miR-129-1-3p, miR-150-3p) induced IL-12.
Conclusions:
- Demonstrated a novel role for specific miRNAs in MAS pathogenesis.
- Highlighted the involvement of FGRP and IL-12 pathways in MAS.
- Proposed miRNA mimic therapy and FCGR gene overexpression as potential therapeutic and diagnostic strategies for MAS.

